Dr.Kirti Singh
Co-existence of ocular and systemic morbidities in a patient of primary and secondary glaucoma makes the treatment individualized, requiring out of textbook decisions requiring analytical skills. Such decisions require a structured road map with treatment algorithms. This course attempts to delineate common patient based approaches – of glaucoma suspect with altered lens dynamics, post-surgical conditions of keratoplasty, refractive surgery, vitreoretinal surgery, steroid induced glaucoma in steroid dependent cases, coexisting diabetes and hypertension. Algorithms will be given for different phaco manoeuvres in filtered eyes and strategies for improving patient adherence. Special emphasis will be on prophylaxis of post-surgery glaucoma’s, altered blood flow dynamics and optimal doctor patient communication employing empathy.
Video assisted teaching would be used wherever required and the glaucoma algorithms will be summarized in the end followed by interactive session.
| 1 | Glaucoma suspect PACS v OAG. Different approaches & special take on lens extraction in PACS (8 mins) | Dr.Maj Gen (Mrs ) Sagarika Patyal | |
| 2 | Follow up protocol and management of suspected glaucoma in young patient after refractive surgery (8 mins) | Dr.Neera Agrawal | |
| 3 | Steroid induced glaucoma: treatment, screening & attributing causality to drug or disease (8 mins) | Dr.(col) Madhu Bhaduria | |
| 4 | Phaco in presence of filter and advanced glaucoma. How to do it, what is its impact on the bleb? (8 mins) | Dr.Kirti Singh | watch video |
| 5 | Post-keratoplasty glaucoma: monitoring, treatment options with emphasis on surgical prophylaxis (8 mins) | Dr.Sujata Das | |
| 7 | The non-complaint patient: strategies to improve drug adherence tailored to age & social profile (8 mins) | Dr.Sood Devindra | watch video |
| 7 | Treatment options in co-existent diabetes or hypertension emphasizing blood flow dynamics (8 mins) | Dr.Chandrima Paul | watch video | Keynote Address by : Management of Neovascular Glaucoma (10 mins) | Dr. PETER A. NETLAND | watch video |
| Panel Discussion : (14 mins.) |
Leave a Comment